Tilman Todenhöfer (@ttodenhoefer) 's Twitter Profile
Tilman Todenhöfer

@ttodenhoefer

ID: 2584738447

linkhttp://www.studienurologie.de calendar_today23-06-2014 23:09:28

73 Tweet

161 Followers

43 Following

SIU-Urology (@siu_urology) 's Twitter Profile Photo

Register today for the next SIU Bench to Bedside Meeting and join some of the biggest experts in bladder, kidney and prostate cancers on May 21-22 on #SIUAcademy for free: ow.ly/wWa250DI4zJ Peter Black Stacy Loeb, MD Ashish M. Kamat, MD, MBBS Simon Tanguay

Register today for the next SIU Bench to Bedside Meeting and join some of the biggest experts in bladder, kidney and prostate cancers on May 21-22 on #SIUAcademy for free: ow.ly/wWa250DI4zJ 
<a href="/pcvblack/">Peter Black</a> <a href="/LoebStacy/">Stacy Loeb, MD</a> <a href="/UroDocAsh/">Ashish M. Kamat, MD, MBBS</a> <a href="/SiTanguay/">Simon Tanguay</a>
Peter Black (@pcvblack) 's Twitter Profile Photo

This one is a must-see for NMIBC aficianados - hits many high points clearly and succinctly. Look for it on-demand on #SIUAcademy Tilman Todenhöfer #B2BGUCancerTriad

SIU-Urology (@siu_urology) 's Twitter Profile Photo

Join #B2BGUCancerTriad experts Drs Tilman Todenhöfer, Matt Galsky, Kilian Gust and KSridhar as they tackle the timeliest issues in BCa - including the impact of #COVID19 on pt care - with this lively roundtable discussion. bit.ly/2TxsLK2 #openaccess

Join #B2BGUCancerTriad experts Drs <a href="/ttodenhoefer/">Tilman Todenhöfer</a>, <a href="/MattGalsky/">Matt Galsky</a>, <a href="/KilianGust/">Kilian Gust</a> and <a href="/kalasri3/">KSridhar</a> as they tackle the timeliest issues in BCa - including the impact of #COVID19 on pt care - with this lively roundtable discussion. bit.ly/2TxsLK2 #openaccess
SIU-Urology (@siu_urology) 's Twitter Profile Photo

From the role of urine markers, to systemic and intravesical drugs and the future of second-line therapy for BCa, watch #B2BGUCancerTriad experts discuss the biggest questions in #bladdercancer management. Connect for free on #SIUAcademy: bit.ly/2TxsLK2 #openaccess

From the role of urine markers, to systemic and intravesical drugs and the future of second-line therapy for BCa, watch #B2BGUCancerTriad experts discuss the biggest questions in #bladdercancer management. Connect for free on #SIUAcademy: bit.ly/2TxsLK2
#openaccess
UroToday.com (@urotoday) 's Twitter Profile Photo

Clinical benefit and safety profile of darolutamide in patients who crossed over to darolutamide from PBO during the open-label period of the phase 3 #ARAMIS study. Presentation by Susan Feyerabend. #EAU21 written coverage by Thenappan (Thenu) Chandrasekar, MD > bit.ly/3B0JAOs European Association of Urology (EAU)

Clinical benefit and safety profile of darolutamide in patients who crossed over to darolutamide from PBO during the open-label period of the phase 3 #ARAMIS study. Presentation by Susan Feyerabend. #EAU21 written coverage by <a href="/tchandra_uromd/">Thenappan (Thenu) Chandrasekar, MD</a> &gt; bit.ly/3B0JAOs <a href="/Uroweb/">European Association of Urology (EAU)</a>
Société Internationale d'Urologie Journal (@siu_journal) 's Twitter Profile Photo

📔 You can now access the #B2BGUCancerTriad proceedings, published as a supplement to the #SIUJ July issue. Review the latest updates on #BCa, #RCC and #PCa that were presented by expert faculty: ow.ly/ho3i50FyXoh Peter Black Jeremy Teoh Stacy Loeb, MD Ashish M. Kamat, MD, MBBS Simon Tanguay

📔 You can now access the #B2BGUCancerTriad proceedings, published as a supplement to the #SIUJ July issue. Review the latest updates on #BCa, #RCC and #PCa that were presented by expert faculty: ow.ly/ho3i50FyXoh 
<a href="/pcvblack/">Peter Black</a> <a href="/jteoh_hk/">Jeremy Teoh</a> <a href="/LoebStacy/">Stacy Loeb, MD</a>
<a href="/UroDocAsh/">Ashish M. Kamat, MD, MBBS</a> <a href="/SiTanguay/">Simon Tanguay</a>
SIU-Urology (@siu_urology) 's Twitter Profile Photo

Watch this Case-Based Panel on Immune-Related Adverse Events with Drs Kilian Gust, Srikala Sridhar, Tilman Todenhöfer and Tian Zhang, from the #B2BGUCancerTriad meeting, now #ondemand. Access is free: ow.ly/9QuK50FCl0b Kilian Gust KSridhar Tilman Todenhöfer Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky)

Watch this Case-Based Panel on Immune-Related Adverse Events with Drs Kilian Gust, Srikala Sridhar, Tilman Todenhöfer and Tian Zhang, from the #B2BGUCancerTriad meeting, now #ondemand. 
Access is free: ow.ly/9QuK50FCl0b 
<a href="/KilianGust/">Kilian Gust</a> <a href="/kalasri3/">KSridhar</a> <a href="/ttodenhoefer/">Tilman Todenhöfer</a> <a href="/TiansterZhang/">Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky)</a>
IBCN (@ibcn1997) 's Twitter Profile Photo

📣We are excited to kick off our 2021 IBCN Update Series September 25, 1600-1730 CET ‘ctDNA and bladder cancer’ Tilman Todenhöfer Lars Dyrskjøt Alex Wyatt Matt Galsky. Open for members➡️inquire below to join, get info, meeting links, and more! ibcnweb.net/upcoming-meeti…

📣We are excited to kick off our 2021 IBCN Update Series September 25,
1600-1730 CET ‘ctDNA and bladder cancer’ <a href="/ttodenhoefer/">Tilman Todenhöfer</a> <a href="/LDyrskjot/">Lars Dyrskjøt</a> <a href="/ResearchWyatt/">Alex Wyatt</a> <a href="/MattGalsky/">Matt Galsky</a>. Open for members➡️inquire below to join, get info, meeting links, and more! ibcnweb.net/upcoming-meeti…
IBCN (@ibcn1997) 's Twitter Profile Photo

IBCN Webinar Series continues with another high impact presentation by Alex Wyatt regarding ctDNA in metastatic setting! Powerhouse talks and impressive attendance with leaders in bladder cancer!

IBCN Webinar Series continues with another high impact presentation by <a href="/ResearchWyatt/">Alex Wyatt</a> regarding ctDNA in metastatic setting! Powerhouse talks and impressive attendance with leaders in bladder cancer!
Tilman Todenhöfer (@ttodenhoefer) 's Twitter Profile Photo

EU CHMP recommends approval of Olaparib/Abiraterone for first-line mCRPC treatment - Surprising as OS results are still immature. Arun Azad Alex Wyatt UroToday.com @alkretsc_urol Sebastian Frees Petros Grivas astrazeneca.com/media-centre/p…